Novartis Pharma B.V.

Location

Noord-Holland

Founded

1948-02-10

Risk Signals

21160 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about Novartis Pharma B.V.

Live alerts from global media, monitored by Business Radar

Novartis is fighting for the trust of investors: the management duo is in debt

2023-07-17 (watson.ch)

Novartis is fighting for the trust of investors: the management duo is in debt

It looked like a good year at Novartis - until the patent dispute over sales champion Entresto startled the shareholders.

Read more
Novartis is fighting for the trust of investors: the management duo is in debt

2023-07-17 (watson.ch)

Novartis is fighting for the trust of investors: the management duo is in debt

It looked like a good year at Novartis - until the patent dispute over sales champion Entresto startled the shareholders.

Read more
OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2022

2022-09-15 (globenewswire.com)

OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2022

OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2022 SIGNIFICANT STRATEGIC AND OPERATIONAL PROGRESS TOWARDS BECOMING A GLOBAL VIRAL...

Read more
Aspen Pharmacare agrees to sell Japanese unit

2019-11-11 (businesslive.co.za)

Aspen Pharmacare agrees to sell Japanese unit

Aspen has been disposing of assets to bring down debt, and want to sell its Japanese operations to Sandoz, a division of Switzerland-based Novartis

Read more
Aspen Pharmacare agrees to sell Japanese unit

2019-11-11 (businesslive.co.za)

Aspen Pharmacare agrees to sell Japanese unit

Aspen has been disposing of assets to bring down debt, and want to sell its Japanese operations to Sandoz, a division of Switzerland-based Novartis

Read more
Aspen Pharmacare agrees to sell Japanese unit

2019-11-11 (businesslive.co.za)

Aspen Pharmacare agrees to sell Japanese unit

Aspen has been disposing of assets to bring down debt, and want to sell its Japanese operations to Sandoz, a division of Switzerland-based Novartis

Read more
Takeda sells Shire’s Xiidra, transfers 400 staffers to Novartis in $3.4B deal

2019-05-09 (fiercepharma.com)

Takeda sells Shire’s Xiidra, transfers 400 staffers to Novartis in $3.4B deal

Takeda is looking to lighten the huge debt burden from the Shire buyout. Novartis wants to beef up its eye medicine portfolio after the Alcon spinoff. | Takeda is looking to lighten the huge debt burden from the Shire buyout.

Read more
The staff and the debt collectors who are doing psychotherapy are screaming against Periodista.gr - In passing, but first...

2018-02-22 (periodista.gr)

The staff and the debt collectors who are doing psychotherapy are screaming against Periodista.gr - In passing, but first...

Yesterday's revelatory report about the family's sordid past caused a sensation

Read more
Oxford BioMedica refinances debt

2017-07-04 (investorschronicle.co.uk)

Oxford BioMedica refinances debt

The group has taken out another very expensive loan

Read more
XOMA Announces Development and Commercialization Agreement for First-in-Class Anti-TGF-beta Antibody Program in Immuno-Oncology

2015-10-01 (globenewswire.com)

XOMA Announces Development and Commercialization Agreement for First-in-Class Anti-TGF-beta Antibody Program in Immuno-Oncology

BERKELEY, Calif., Oct. 1, 2015 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies,...

Read more
Torrent Pharma to buy Elder's India business for Rs 2,000 cr

2013-03-31 (business-standard.com)

Torrent Pharma to buy Elder's India business for Rs 2,000 cr

Read more about Torrent Pharma to buy Elder's India business for Rs 2,000 cr on Business Standard. Deal to give debt relief to Mumbai-based seller; analysts expect pressure on Torrent's margins

Read more
Torrent Pharma to buy Elder's India business for Rs 2,000 cr

2013-03-31 (business-standard.com)

Torrent Pharma to buy Elder's India business for Rs 2,000 cr

Read more about Torrent Pharma to buy Elder's India business for Rs 2,000 cr on Business Standard. Deal to give debt relief to Mumbai-based seller; analysts expect pressure on Torrent's margins

Read more

Never miss a headline about Novartis Pharma B.V.

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages